Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnoSer provides advanced preclinical CRO services with a focus on translational in vitro and in vivo models. Their platforms include unique mouse models for kidney disease, patient-derived xenografts/organoids for oncology drug screening, and organoid technology for neurodegenerative disorders. They support early-stage drug development with expertise in safety/efficacy testing, pharmacology, imaging, digital pathology, and more. No clinical trial results are reported as they operate at the preclinical stage
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InnoSer.